Biotech · Private company
Veeva Systems
Track this companyFree. Adds Veeva Systems to your Dealase workspace and tells you when its record changes.
Clinical trials65 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)PHASE2 · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07881952 · fetched Nov 12, 2026
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)PHASE3 · RECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07637734 · fetched Nov 12, 2026
- Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)PHASE3 · RECRUITING · started Mar 11, 2026ClinicalTrials.gov NCT07457918 · fetched Nov 12, 2026
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 17, 2025ClinicalTrials.gov NCT07246590 · fetched Nov 12, 2026
- Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMITRECRUITING · started Sep 25, 2024ClinicalTrials.gov NCT06564974 · fetched Nov 12, 2026
- Long Term Hemodialysis Catheters (LTHD) Post Market Clinical Follow up (PMCF)WITHDRAWN · started Mar 30, 2022ClinicalTrials.gov NCT04782297 · fetched Nov 12, 2026